Try our Advanced Search for more refined results
April 03, 2020
MSP Recovery Claims, Series LLC, v. Aurobindo Pharma, Ltd. et al
Case Number:
1:20-cv-21456
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 06, 2020
Aurobindo, Heritage Accused Of Hiding Drug Contamination
Generic versions of Metformin produced by Aurobindo Pharma and Heritage Pharmaceuticals were contaminated with a possible carcinogen, according to a proposed Florida class action seeking to recover $124 million that health insurers paid for the popular diabetes drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login